Newsletters
- Bay Area Newsletter
- Greater Los Angeles Newsletter
- Group Purchasing Newsletter
- Public Policy Newsletter
- Regulatory & Reimbursement Newsletter
- San Diego Newsletter
Home / Newsletters / Public Policy Newsletter

The recent roundtable with Bay Area Congressman Kevin Mullin, the 12 Biocom supported state bills that have been signed into effect, CMS’s new finalized GLOBE Model, two new fees being considered for facilities regulated under CUPA programs in LA and more.

Funding Bill Temporarily Blocks OMB’s Proposed Grant-Making Rule; MFN Drug Pricing Agreements Expand; Significant Amendments Secured for the Cartwright Act; New Simplified Guide for Doing Business in Berkeley; Upcoming Committees; and more.

Biocom’s Annual Sacramento Reception; Updates on the Proposed OMB Grantmaking Rule; Assembly Select Committee’s Meeting on AI in Life Sciences; Labs of the Future Workshop and Happy Hour; Upcoming Committees and Events; and more.

Biocom’s Recently Published 2026 Economic Impact Report; OMB’s Proposed Regulation on Federal Research Grants; R&D Tax Credit Negotiations; San Francisco and Berkeley Pass Budgets to Close Deficits; Apply for California Competes Tax Credit Program; and more.

Biocom CEO Advocates in Washington DC; CA’s Primary Elections Results; State Budget Threatens R&D tax credit; Patents, NIH and data privacy statement submissions; and more.

Biocom CEO Advocates for the Life Sciences in California, D.C. and China; The Governor’s Proposed Permanent R&D Credit Limitation; Berkeley Faces Looming Budget Deficit and Service Reductions; New Life Science Funding and Infrastructure in LA County; and more.

SBIR and STTR Reauthorizations Signed Into Law; California Adopts Senate Resolution 88; Biocom Position on Indirect Source Rule Approved; Potential Transit Funding Measure in the Bay Area; LA County Life Science Growth Strategy; and more.

SBIR/STTR Reauthorization with President; Biocom Hosts Roundtables with Public Officials; SF Looking Into Tax Cuts; Pasadena’s New R&D Facilities Plans; and more.

Biocom CEO Discusses SBIR/STTR Reauthorization; FY26 Spending Package Enacted; Biocom Joins Group Opposing AB 1776; Roundtable with SD Police Chief; New PermitSF Portal; LA’s State of the City Address; and more.

New Federal Healthcare Plan Proposal; Funding Deadline in Congress; SB 895 Research Bond Introduced in State Senate; San Diego Mayor Gives State of the City Address; San Mateo Gains New Leadership; New MOU Signed in LA; and more.